We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Financials 11.56%
3 Healthcare 11.43%
4 Consumer Discretionary 10.98%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVO icon
2926
Mission Produce
AVO
$1.15B
$63K ﹤0.01%
3,291
+2,320
+239% +$44.5K
BDN
2927
Brandywine Realty Trust
BDN
$542M
$63K ﹤0.01%
4,890
+691
+16% +$8.44K
EWH icon
2928
iShares MSCI Hong Kong ETF
EWH
$1.21B
$63K ﹤0.01%
2,376
+1,156
+95% +$30.4K
GLSI icon
2929
Greenwich LifeSciences
GLSI
$237M
$63K ﹤0.01%
+1,853
New +$63.1K
JILL icon
2930
J. Jill
JILL
$288M
$63K ﹤0.01%
6,461
+5,610
+659% +$29.6K
NNDM
2931
Nano Dimension
NNDM
$348M
$63K ﹤0.01%
7,384
-826
-10% -$9.49K
PNRG icon
2932
PrimeEnergy Resources
PNRG
$314M
$63K ﹤0.01%
1,213
+226
+23% +$10.6K
RLMD icon
2933
Relmada Therapeutics
RLMD
$508M
$63K ﹤0.01%
1,798
+620
+53% +$21.7K
STN icon
2934
Stantec
STN
$8.56B
$63K ﹤0.01%
1,483
+976
+193% +$37.6K
ZNTL icon
2935
Zentalis Pharmaceuticals
ZNTL
$254M
$63K ﹤0.01%
1,444
+726
+101% +$31.3K
BCOV
2936
DELISTED
Brightcove, Inc.
BCOV
$63K ﹤0.01%
3,128
-5,418
-63% -$109K
AFI
2937
DELISTED
Armstrong Flooring, Inc.
AFI
$63K ﹤0.01%
12,758
+9,994
+362% +$47.2K
AQST icon
2938
Aquestive Therapeutics
AQST
$510M
$62K ﹤0.01%
12,044
+7,547
+168% +$40.1K
BANF icon
2939
BancFirst
BANF
$3.88B
$62K ﹤0.01%
878
+160
+22% +$10.6K
CPF icon
2940
Central Pacific Financial
CPF
$1B
$62K ﹤0.01%
2,300
-519
-18% -$11.9K
NRC icon
2941
NRC Health Common Stock
NRC
$471M
$62K ﹤0.01%
1,336
-3,011
-69% -$146K
PGEN icon
2942
Precigen
PGEN
$2.26B
$62K ﹤0.01%
8,945
+6,167
+222% +$52.1K
RMR icon
2943
The RMR Group
RMR
$347M
$62K ﹤0.01%
1,508
+113
+8% +$4.46K
UI icon
2944
Ubiquiti
UI
$35B
$62K ﹤0.01%
207
-94
-31% -$29.6K
WSR
2945
DELISTED
Whitestone REIT
WSR
$62K ﹤0.01%
6,361
-775
-11% -$6.94K
WVE icon
2946
Wave Life Sciences
WVE
$1.01B
$62K ﹤0.01%
11,066
+6,785
+158% +$65.2K
SHLX
2947
DELISTED
Shell Midstream Partners, L.P.
SHLX
$62K ﹤0.01%
4,650
+2,338
+101% +$27.7K
BATRK icon
2948
Atlanta Braves Holdings Series B
BATRK
$3.4B
$61K ﹤0.01%
2,199
-390
-15% -$11K
BMRC icon
2949
Bank of Marin Bancorp
BMRC
$466M
$61K ﹤0.01%
1,543
-2,262
-59% -$87.2K
CHRD icon
2950
Chord Energy
CHRD
$7.42B
$61K ﹤0.01%
+1,022
New +$51.9K

Similar funds

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.